enablement

15 cases — ← All topics

Case Title Lower Court Docketed Status Flags Tags Question Presented
25-570 Agilent Technologies, Inc. v. Synthego Corp. Federal Circuit 2025-11-13 Pending Response RequestedResponse Waived anticipation burden-of-proof enablement patent-validity printed-publications prior-art 1. Should printed publications be presumed to be enabling when a party challenging the validity of issued patent claims asserts that a printed publ…
25-5989 Chian Chiu Li v. Apple, Inc. Federal Circuit 2025-10-29 Denied Response WaivedIFP enablement negative-limitation patent-law specification-requirement statutory-interpretation written-description Section 112(a) of Title 35 requires that a patent include a specification containing "a written description of the invention ... in such full, clear, …
21-1566 Juno Therapeutics, Inc., et al. v. Kite Pharma, Inc. Federal Circuit 2022-06-15 Denied Amici (5)Relisted (6) 35-usc-112(a) enablement federal-circuit invention-scope inventor-possession patent patent-law patent-specification statutory-interpretation written-description Whether the written description requirement under 35 USC 112(a) should be measured by the statutory standard or the Federal Circuit's 'possession' tes…
21-1281 Interactive Wearables, LLC v. Polar Electro Oy, et al. Federal Circuit 2022-03-22 Denied CVSGAmici (1)Response RequestedResponse WaivedRelisted (3) 35-usc-101 abstract-idea claim-construction enablement judicial-exceptions legal-standard patent-eligibility patent-subject-matter section-101 two-step-framework What is the appropriate standard for determining whether a patent claim is 'directed to' a patent-ineligible concept under step one of the Court's two…
21-812 WhitServe LLC v. Dropbox, Inc. Federal Circuit 2021-12-01 Denied Response Waived 35-usc-101 enablement patent-eligibility person-having-ordinary-skill-in-the-art presumption-of-validity rule-12(b)(6) rule-12b6 section-101 technological-improvement If a patentee makes factual assertions and provides supporting evidence that its claimed invention is directed to patent-eligible subject matter under…
21-757 Amgen Inc., et al. v. Sanofi, et al. Federal Circuit 2021-11-22 Judgment Issued CVSGAmici (33)Response RequestedRelisted (4) 35-usc-112 claim-construction claim-scope enablement enablement-requirement invention-disclosure judicial-review patent patent-law statutory-interpretation undue-experimentation written-description Whether enablement is a question of fact or law
20-7267 Kevin L. Martin v. Cathleen Capron, et al. Seventh Circuit 2021-03-01 Dismissed Response WaivedIFP 35-usc-112 court-of-appeals enablement invention patent prior-art Whether the court of appeals erred in finding that the claimed invention meets the enablement requirement of 35 U.S.C. § 112
20-380 Idenix Pharmaceuticals LLC, et al. v. Gilead Sciences, Inc. Federal Circuit 2020-09-24 Denied Amici (3)Response RequestedResponse WaivedRelisted (2) 35-usc-112a enablement genus-claim genus-claims patent patent-law pharmaceutical-innovation pharmaceuticals statutory-interpretation written-description Whether the Federal Circuit's genus-claim-specific enablement rule and separate 'possession' requirement are consistent with 35 U.S.C. § 112(a)
20-74 Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director, United States Patent and Trademark Office v. Eugene H. Luoma, et al. Federal Circuit 2020-07-27 GVR Response WaivedRelisted (2) administrative-law america-invents-act enablement intellectual-property judicial-review obviousness patent-eligibility patent-review patent-trial-and-appeal-board patent-validity prior-art written-description Whether the Patent Trial and Appeal Board's application of the statutory requirements for patentability under 35 U.S.C. §§ 101, 102, 103, and 112 was …
19-8094 Caleb S. Motupalli v. Andrei Iancu, Director, United States Patent and Trademark Office Federal Circuit 2020-03-24 Denied Response WaivedIFP 35-usc-112 america-invents-act enablement interdisciplinary-invention interdisciplinary-team patent-enablement patent-examination patent-specification pre-aia pro-se single-skilled-person waiver Does the Leahy-Smith America Invents Act (AIA) permit the retroactive application of a scintilla of inadequacy in Pre-AIA to overturn precedent by ins…
19-1073 Enzo Life Sciences, Inc. v. Roche Molecular Systems, Inc., et al. Federal Circuit 2020-03-02 Denied Response Waived 35-usc-112 35-usc-282 clear-and-convincing-standard enablement inoperability non-enabled-claims patent-law patent-validity presumption-of-validity statutory-interpretation unpredictability Whether patent claims that cover a class may be invalidated as non-enabled under 35 U.S.C. § 112 based on a finding of high unpredictability in the ar…
19-584 Nuvo Pharmaceuticals (Ireland) Designated Activity Company, et al. v. Dr. Reddy's Laboratories Inc., et al. Federal Circuit 2019-11-04 Denied Response Waived 35-usc-112 enablement federal-circuit innovation patent patent-law pharmaceutical pharmaceutical-composition prior-art written-description Whether the Federal Circuit erred by holding that, whenever the prior art teaches away from a pharmaceutical composition, the written description of a…
18-1515 Eli Lilly and Company v. Erfindergemeinschaft UroPep GbR Federal Circuit 2019-06-06 Denied Amici (3)Response RequestedResponse WaivedRelisted (2) 35-usc-112 ariad-pharmaceuticals claim-construction enablement functional-claiming halliburton-oil-well-cementing halliburton-oil-well-cementing-co-v-walker halliburton-precedent patent-claims patent-eligibility patent-law point-of-novelty single-step-claim written-description Whether a single-step patent claim that describes its point of novelty solely in functional terms violates the rule against functional claiming
18-190 Queen's University at Kingston v. Samsung Electronics Co., Ltd., et al. Federal Circuit 2018-08-13 Denied Response Waived administrative-procedure-act burden-of-proof due-process enablement inter-partes-review patent-invalidity prior-art Does the Federal Circuit's requirement that patent owners negate enablement of prior art in the first instance invert the statutory burden of proving …
18-127 Amgen Inc., et al. v. Sanofi, et al. Federal Circuit 2018-07-27 Denied Amici (1)Response RequestedRelisted (2) 35-usc-112 biotechnology enablement federal-circuit innovation patent-law possession statutory-interpretation written-description Whether the standard for determining the adequacy of the 'written description of the invention' should be as the statute says—that the description mus…